Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 01 January 2020 |
| Author/s |
author: Abby Willcox Barnaby C Reeves |
| Publication date | January 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |